NCT03078023View on ClinicalTrials.gov

Sponge and Eosinophil Peroxidase (EPO) Staining

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

July 19, 2019

Study Completion Date

July 19, 2019

Conditions
Eosinophilic Esophagitis
Interventions
DEVICE

swallowed sponge device

Swallowed sponge: Subjects having a clinical upper endoscopy will be asked to swallow the sponge 2 hours prior to EGD

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER